Drugs / sodium borocaptate
sodium borocaptate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00062348 | Apr 2003 → Dec 2007 | colorectal cancer, head and neck cancer, metastatic malignant neoplasm | European Organisation for Research and Treatment of Cancer - EORTC | Completed | No outcome recorded |
| Phase 1 | NCT00004015 | Jun 2002 → Jul 2003 | central nervous system neoplasm | European Organisation for Research and Treatment of Cancer - EORTC | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium borocaptate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00062348 ↗ |
| Known as | borocaptate sodium | “Determine systemic and local toxicity of borocaptate sodium with boron neutron capture therapy (BNCT) following craniotomy with gross total resection in patients with...” NCT00004015 ↗1“Metabolism of borono-phenylalanine-fructose complex (BPA-fr) and borocaptate sodium (BSH) in cancer patients--results from EORTC trial 11001.” PMID 19735988 ↗ Aug 2009 |
| Known as | BSH | “Patients receive sodium borocaptate (BSH) IV over 1 hour.” NCT00062348 ↗ |
| Route | Intravenous | “BSH IV over 1 hour” NCT00062348 ↗ |